Literature DB >> 15557587

Initial viral load and the outcomes of SARS.

Chung-Ming Chu1, Leo L M Poon, Vincent C C Cheng, Kin-Sang Chan, Ivan F N Hung, Maureen M L Wong, Kwok-Hung Chan, Wah-Shing Leung, Bone S F Tang, Veronica L Chan, Woon-Leung Ng, Tiong-Chee Sim, Ping-Wing Ng, Kin-Ip Law, Doris M W Tse, Joseph S M Peiris, Kwok-Yung Yuen.   

Abstract

BACKGROUND: Severe acute respiratory syndrome (SARS) is caused by a novel coronavirus. It may progress to respiratory failure, and a significant proportion of patients die. Preliminary data suggest that a high viral load of the SARS coronavirus is associated with adverse outcomes in the intensive care unit, but the relation of viral load to survival is unclear.
METHODS: We prospectively studied an inception cohort of 133 patients with virologically confirmed SARS who were admitted to 2 general acute care hospitals in Hong Kong from Mar. 24 to May 4, 2003. The patients were followed until death or for a minimum of 90 days. We used Cox proportional hazard modelling to analyze potential predictors of survival recorded at the time of presentation, including viral load from nasopharyngeal specimens (measured by quantitative reverse transcriptase polymerase chain reaction [PCR] of the SARS-associated coronavirus).
RESULTS: Thirty-two patients (24.1%) met the criteria for acute respiratory distress syndrome, and 24 patients (18.0%) died. The following baseline factors were independently associated with worse survival: older age (61-80 years) (adjusted hazard ratio [HR] 5.24, 95% confidence interval [CI] 2.03-13.53), presence of an active comorbid condition (adjusted HR 3.36, 95% CI 1.44-7.82) and higher initial viral load of SARS coronavirus, according to quantitative PCR of nasopharyngeal specimens (adjusted HR 1.21 per log10 increase in number of RNA copies per millilitre, 95% CI 1.06-1.39).
INTERPRETATION: We found preliminary evidence that higher initial viral load is independently associated with worse prognosis in SARS. Mortality data for patients with SARS should be interpreted in light of age, comorbidity and viral load. These considerations will be important in future studies of SARS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557587      PMCID: PMC527336          DOI: 10.1503/cmaj.1040398

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  18 in total

1.  Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

Authors:  Christopher M Booth; Larissa M Matukas; George A Tomlinson; Anita R Rachlis; David B Rose; Hy A Dwosh; Sharon L Walmsley; Tony Mazzulli; Monica Avendano; Peter Derkach; Issa E Ephtimios; Ian Kitai; Barbara D Mederski; Steven B Shadowitz; Wayne L Gold; Laura A Hawryluck; Elizabeth Rea; Jordan S Chenkin; David W Cescon; Susan M Poutanen; Allan S Detsky
Journal:  JAMA       Date:  2003-05-06       Impact factor: 56.272

2.  Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS).

Authors:  J W M Chan; C K Ng; Y H Chan; T Y W Mok; S Lee; S Y Y Chu; W L Law; M P Lee; P C K Li
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

3.  Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis.

Authors:  Raymond S M Wong; Alan Wu; K F To; Nelson Lee; Christopher W K Lam; C K Wong; Paul K S Chan; Margaret H L Ng; L M Yu; David S Hui; John S Tam; Gregory Cheng; Joseph J Y Sung
Journal:  BMJ       Date:  2003-06-21

4.  Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS).

Authors:  Leo L M Poon; On Kei Wong; Kwok Hung Chan; Winsie Luk; Kwok Yung Yuen; Joseph S M Peiris; Yi Guan
Journal:  Clin Chem       Date:  2003-06       Impact factor: 8.327

5.  Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome.

Authors:  Enders K O Ng; David S Hui; K C Allen Chan; Emily C W Hung; Rossa W K Chiu; Nelson Lee; Alan Wu; Stephen S C Chim; Yu K Tong; Joseph J Y Sung; John S Tam; Y M Dennis Lo
Journal:  Clin Chem       Date:  2003-12       Impact factor: 8.327

6.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.

Authors:  J S M Peiris; C M Chu; V C C Cheng; K S Chan; I F N Hung; L L M Poon; K I Law; B S F Tang; T Y W Hon; C S Chan; K H Chan; J S C Ng; B J Zheng; W L Ng; R W M Lai; Y Guan; K Y Yuen
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

7.  Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

Authors:  Thijs Kuiken; Ron A M Fouchier; Martin Schutten; Guus F Rimmelzwaan; Geert van Amerongen; Debby van Riel; Jon D Laman; Ton de Jong; Gerard van Doornum; Wilina Lim; Ai Ee Ling; Paul K S Chan; John S Tam; Maria C Zambon; Robin Gopal; Christian Drosten; Sylvie van der Werf; Nicolas Escriou; Jean-Claude Manuguerra; Klaus Stöhr; J S Malik Peiris; Albert D M E Osterhaus
Journal:  Lancet       Date:  2003-07-26       Impact factor: 79.321

8.  Lung pathology of fatal severe acute respiratory syndrome.

Authors:  John M Nicholls; Leo L M Poon; Kam C Lee; Wai F Ng; Sik T Lai; Chung Y Leung; Chung M Chu; Pak K Hui; Kong L Mak; Wilina Lim; Kin W Yan; Kwok H Chan; Ngai C Tsang; Yi Guan; Kwok Y Yuen; J S Malik Peiris
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

9.  Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome.

Authors:  V C C Cheng; I F N Hung; B S F Tang; C M Chu; M M L Wong; K H Chan; A K L Wu; D M W Tse; K S Chan; B J Zheng; J S M Peiris; J J Y Sung; K Y Yuen
Journal:  Clin Infect Dis       Date:  2004-01-29       Impact factor: 9.079

10.  Aetiology: Koch's postulates fulfilled for SARS virus.

Authors:  Ron A M Fouchier; Thijs Kuiken; Martin Schutten; Geert van Amerongen; Gerard J J van Doornum; Bernadette G van den Hoogen; Malik Peiris; Wilina Lim; Klaus Stöhr; Albert D M E Osterhaus
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

View more
  84 in total

1.  Evaluation of real-time reverse transcriptase PCR and real-time loop-mediated amplification assays for severe acute respiratory syndrome coronavirus detection.

Authors:  Leo L M Poon; Bonnie W Y Wong; Kwok H Chan; Stella S F Ng; Kwok Y Yuen; Yi Guan; J S Malik Peiris
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

2.  SARS transmission in Vietnam outside of the health-care setting.

Authors:  P A Tuan; P Horby; P N Dinh; L T Q Mai; M Zambon; J Shah; V Q Huy; S Bloom; R Gopal; J Comer; A Plant
Journal:  Epidemiol Infect       Date:  2006-07-26       Impact factor: 2.451

3.  Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice.

Authors:  Boyd Yount; Rhonda S Roberts; Amy C Sims; Damon Deming; Matthew B Frieman; Jennifer Sparks; Mark R Denison; Nancy Davis; Ralph S Baric
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York.

Authors: 
Journal:  J Am Soc Nephrol       Date:  2020-04-21       Impact factor: 10.121

5.  A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo.

Authors:  Marta L DeDiego; Enrique Alvarez; Fernando Almazán; María Teresa Rejas; Elaine Lamirande; Anjeanette Roberts; Wun-Ju Shieh; Sherif R Zaki; Kanta Subbarao; Luis Enjuanes
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

Review 6.  Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.

Authors:  Vincent C C Cheng; Susanna K P Lau; Patrick C Y Woo; Kwok Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

Review 7.  COVID-19 - Toward a comprehensive understanding of the disease.

Authors:  Maciej M Kowalik; Piotr Trzonkowski; Magdalena Łasińska-Kowara; Andrzej Mital; Tomasz Smiatacz; Miłosz Jaguszewski
Journal:  Cardiol J       Date:  2020-05-07       Impact factor: 2.737

8.  Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease.

Authors:  Luis Enjuanes; Marta L Dediego; Enrique Alvarez; Damon Deming; Tim Sheahan; Ralph Baric
Journal:  Virus Res       Date:  2007-04-09       Impact factor: 3.303

9.  Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice.

Authors:  Jincun Zhao; Jingxian Zhao; Nico Van Rooijen; Stanley Perlman
Journal:  PLoS Pathog       Date:  2009-10-23       Impact factor: 6.823

10.  T cell responses to whole SARS coronavirus in humans.

Authors:  Chris Ka-fai Li; Hao Wu; Huiping Yan; Shiwu Ma; Lili Wang; Mingxia Zhang; Xiaoping Tang; Nigel J Temperton; Robin A Weiss; Jason M Brenchley; Daniel C Douek; Juthathip Mongkolsapaya; Bac-Hai Tran; Chen-lung Steve Lin; Gavin R Screaton; Jin-lin Hou; Andrew J McMichael; Xiao-Ning Xu
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.